<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiovascular manifestations of <z:e sem="disease" ids="C0023931" disease_type="Disease or Syndrome" abbrv="">Lobstein's disease</z:e> are rare, probably unrecognized, and determining factors for the final prognosis, the most frequent lesion being <z:e sem="disease" ids="C0003504" disease_type="Disease or Syndrome" abbrv="ai">aortic incompetence</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The eleventh case to be reported with pathological findings in the literature is described </plain></SENT>
<SENT sid="2" pm="."><plain>This complication is usually found in men, blood regurgitation being large in amount, symptomatic, and progressive </plain></SENT>
<SENT sid="3" pm="."><plain>Its mechanism is related less to <z:mpath ids='MPATH_66'>dilatation</z:mpath> of the aorta and its ring than to valvular changes, they being frequently bicuspid and dysplasic </plain></SENT>
<SENT sid="4" pm="."><plain>Histological findings, not however pathognomonic, are myxoid degeneration in the valves and parietal cystic <z:mp ids='MP_0001651'>necrosis</z:mp> in the aortic wall </plain></SENT>
<SENT sid="5" pm="."><plain>Apart from the absence of an <z:hpo ids='HP_0002617'>aneurysm</z:hpo> and <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>, macro- and microscopic lesions are similar to those observed in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> and <z:e sem="disease" ids="C0029434" disease_type="Disease or Syndrome" abbrv="">osteogenesis imperfecta</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Operative therapy was employed in <z:hpo ids='HP_0000001'>all</z:hpo> eleven cases, with three postoperative <z:hpo ids='HP_0011420'>deaths</z:hpo> and three later <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Certain complications arise from uncontrollable severe <z:mp ids='MP_0001914'>hemorrhage</z:mp>, which justifies the use of valve heterografts not requiring antivitamin K administration </plain></SENT>
</text></document>